The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Adherence to inhaled therapy, mortality and hospital admission in COPD
Open accessAbstract
BACKGROUND: Little is known about adherence to inhaled medication in chronic obstructive pulmonary disease (COPD) and the impact on mortality and morbidity. METHODS: Data on drug adherence from a randomised double-blind trial comparing inhaled salmeterol 50 microg + fluticasone propionate 500 microg twice daily with placebo and each drug individually in 6112 patients with moderate to severe COPD over 3 years in the TORCH study were used. All-cause mortality and exacerbations leading to hospital admission were primary and secondary end points. The study of adherence was not specified a priori as an ancillary study. RESULTS: Of the 4880 patients (79.8%) with good adherence defined as >80% use of study medication, 11.3% died compared with 26.4% of the 1232 patients (20.2%) with poor adherence. The annual rates of hospital admission for exacerbations were 0.15 and 0.27, respectively. The association between adherence and mortality remained unchanged and statistically significant after adjusting for other factors related to prognosis (hazard ratio 0.40 (95% CI 0.35 to 0.46), p<0.001). The association was even stronger when analysing on-treatment deaths only. Similarly, the association between adherence and hospital admission remained unchanged and significant in a multivariate analysis (rate ratio 0.58 (95% CI 0.44 to 0.73, p<0.001). The association between increased adherence and improved mortality and reduction in hospital admission was independent of study treatment. The effect of treatment was more pronounced in patients with good adherence than in those with poor adherence. CONCLUSION: Adherence to inhaled medication is significantly associated with reduced risk of death and admission to hospital due to exacerbations in COPD. Further research is needed to understand these strong associations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“There are several risk factors for COPD-related hospital admissions, including nonadherence to medication [5].”
From Using Robots at Home to Support Patients With Chronic Obstructive Pulmonary Disease: Pilot Randomized Controlled Trial (2018) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationRabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Self-citationSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234
Self-citationRodríguez, R. (2007) · Cited by 1,412
A meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353 · cited 3×
“treatment with a drug with positive effects to that in patients receiving placebo.(1) Most of the studies”
BackgroundMethodResultInfluentialGarcia-Aymerich, J., Lange, P., Benet, M., Schnohr, P., & Anto, J. M. (2006) · Thorax · doi:10.1136/thx.2006.060145 · Cited by 1,113
Mortality in COPD: role of comorbidities
Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G. (2006) · European Respiratory Journal · doi:10.1183/09031936.00133805 · Cited by 1,052
Bourbeau, J. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.5.585 · Cited by 933
The Handbook of health behavior change
(2009) · Choice Reviews Online · doi:10.5860/choice.46-6233 · Cited by 616
Patterns of Comorbidities in Newly Diagnosed COPD and Asthma in Primary Care
Soriano, J. B., Visick, G. T., Muellerova, H., Payvandi, N., & Hansell, A. L. (2005) · Chest · doi:10.1378/chest.128.4.2099 · Cited by 615
Cited by
Sorted by citations
Items 201–300 of 514
Stockley, R. A., Edgar, R. G., Starkey, S., & Turner, A. M. (2018) · Respiratory Research · doi:10.1186/s12931-018-0844-6 · Cited by 21
From treatable traits to GETomics in airway disease: moving towards clinical practice
Papi, A. A., Faner, R., Pavord, I. D., Baraldi, F., McDonald, V. M., Thomas, M. D., Miravitlles, M., Roche, N., & Agustí, A. G. N. (2024) · European Respiratory Review · doi:10.1183/16000617.0143-2023 · Cited by 20
Nguyen, P. L., Uddin, M., Mir, T., Khalil, A., Regmi, N., Pervaiz, A., Hussain, T., Babu, M. A., Ullah, I., Patel, P. J., et al. (2021) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2021.1979500 · Cited by 20
Bronchodilators use in patients with COPD
Hsu, C., Dong, Y., Li, Y.-Y., Chang, C., & Lai, M. (2015) · International Journal of COPD · doi:10.2147/copd.s86198 · Cited by 20
Boland, M. R. S., van Boven, J. F. M., Kruis, A. L., Chavannes, N. H., van der Molen, T., Goossens, L. M. A., & Mölken, M. R. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.11.008 · Cited by 21
Garín, N., Tamames, B. Z., Gras-Martín, L., Milà, R., Lessmann, A. C., Curto, E., Hernández, M., Mestres, C., & Plaza, V. (2023) · Pharmaceuticals · doi:10.3390/ph16030414 · Cited by 19
Vogelmeier, C. F., Beeh, K. M., Schultze, M., Kossack, N., Richter, L., Claussen, J., Compton, C. H., Noorduyn, S. G., Ismaila, A., & Requena, G. (2024) · International Journal of COPD · doi:10.2147/copd.s460903 · Cited by 19
van Boven, J. F. M., van Raaij, J. J., van der Galiën, R., Postma, M. J., van der Molen, T., Dekhuijzen, P. R., & Vegter, S. (2014) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2014.69 · Cited by 19
Fluticasone Furoate/Vilanterol: A Review of Its Use in Chronic Obstructive Pulmonary Disease
McKeage, K. (2014) · Drugs · doi:10.1007/s40265-014-0269-6 · Cited by 18
Predictors of patient adherence to COPD self-management exacerbation action plans
Schrijver, J., Effing, T., Brusse-Keizer, M. G. J., van der Palen, J. A. M., VanderValk, P. D. L. P. M., & Lenferink, A. (2020) · Patient Education and Counseling · doi:10.1016/j.pec.2020.06.015 · Cited by 19
Clinical Control Criteria to Determine Disease Control in Patients with Severe COPD: The CLAVE Study
Soler‐Cataluña, J. J., Almagro, P., Huerta, A. H., Alsina, D. G.-S., & Cosío, B. G. (2021) · International Journal of COPD · doi:10.2147/copd.s285385 · Cited by 18
Sansbury, L. B., Lipson, D. A., Bains, C., Anley, G., Rothnie, K., & Ismaila, A. (2022) · International Journal of COPD · doi:10.2147/copd.s336158 · Cited by 18
Adams, S., & Amalakuhan, B. (2015) · International Journal of COPD · doi:10.2147/copd.s71450 · Cited by 18
Mannino, D. M., Weng, S. F., Germain, G., Boudreau, J., Tardif‐Samson, A., Forero-Schwanhaeuser, S., Laliberté, F., Gravelle, P., Compton, C. H., Noorduyn, S. G., et al. (2024) · Advances in Therapy · doi:10.1007/s12325-024-03088-1 · Cited by 17
Optimizing management of chronic obstructive pulmonary disease in the upcoming decade
Anzueto, A., & Russell, R. E. K. (2011) · International Journal of COPD · doi:10.2147/copd.s13758 · Cited by 17
LaForce, C., Weinstein, C. L. J., Nathan, R. A., Weinstein, S. F., Staudinger, H. W., & Meltzer, E. O. (2011) · Journal of Asthma · doi:10.3109/02770903.2011.587579 · Cited by 17
Can Health Care Organizations Improve Health Behavior and Treatment Adherence?
Bender, B. G. (2013) · Population Health Management · doi:10.1089/pop.2013.0045 · Cited by 21
Gallagher, R. D., Warwick, M., Chenoweth, L., Stein‐Parbury, J., & Milton‐Wildey, K. (2011) · Journal of Nursing and Healthcare of Chronic Illness · doi:10.1111/j.1752-9824.2010.01077.x · Cited by 17
Maes, A. L., DePetrillo, P. B., Siddiqui, S. S., Reisner, C., & Dorinsky, P. (2018) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.585 · Cited by 17
Achterbosch, M., Vart, P., van Dijk, L., & van Boven, J. F. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1283135 · Cited by 18
Clinical use of aclidinium in patients with COPD
Reid, D. J., & Carlson, A. A. (2014) · International Journal of COPD · doi:10.2147/copd.s40193 · Cited by 16
Medication adherence issues in patients: focus on cost
Matsui, D. M. (2013) · Clinical Audit · doi:10.2147/ca.s30125 · Cited by 16
Rodrigo, G. J., & Neffen, H. E. (2016) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2016.11.003 · Cited by 16
Euceda, G., Kong, W.-T., Kapoor, A. D., DiLauro, P. C., Ogunnaike, R., & Chronakos, J. (2018) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.5.3.2017.0177 · Cited by 16
Moretz, C., Bengtson, L. G. S., Sharpsten, L., Koep, E., Le, L. B., Tong, J., Stanford, R. H., Hahn, B. A., & Ray, R. (2019) · International Journal of COPD · doi:10.2147/copd.s213520 · Cited by 16
Medication Compliance in COPD Patients
Polański, J., Chabowski, M., Świątoniowska-Lonc, N., Mazur, G. J., & Jankowska‐Polańska, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_508 · Cited by 18
Dalal, A. A., Yawn, B. P., Raphiou, & Hurley (2010) · International Journal of COPD · doi:10.2147/copd.s4159 · Cited by 16
Bollmeier, S. G., Seaton, T., Prosser, T. R., Chou, Y.-T., Reckenberg, K., Hahn, B. A., Stanford, R. H., & Ray, R. (2019) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.04.017 · Cited by 15
The Utility of Electronic Inhaler Monitoring in COPD Management
Attaway, A. H., Alshabani, K., Bender, B. G., & Hatipoglu, U. S. (2020) · CHEST Journal · doi:10.1016/j.chest.2019.12.034 · Cited by 15
Inhaled β-agonist does not modify sympathetic activity in patients with COPD
Haarmann, H., Mohrlang, C., Tschiesner, U., Rubin, D. B., Bornemann, T., Rüter, K., Bonev, S., Raupach, T., Hasenfuss, G. P., & Andreas, S. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0054-7 · Cited by 15
Tay, T. R., van Boven, J. F. M., Chan, A. H. Y., & Hew, M. J. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.11.027 · Cited by 15
COPD Patients’ Behaviour When Involved in the Choice of Inhaler Device
Bivolaru, S., Constantin, A., Vlase, C.-M., & Guțu, C. (2023) · Healthcare · doi:10.3390/healthcare11111606 · Cited by 14
Nguyen, T. N., Truong, M. T. X., Lam, D. N., Nguyen, H. T. T., Huynh, A. M., Duong, V. K., Vo, T. P. M., Nguyen, T. H. P., Cao, T. T. M., Pham, S. T., et al. (2023) · Patient Education and Counseling · doi:10.1016/j.pec.2023.108037 · Cited by 14
Fenta, E. T., Ayal, B. G., Kidie, A. A., Anagaw, T. F., Mekonnen, T., Bogale, E. K., Berihun, S., Tsega, T. D., Munie, C. M., Fenta, T. T., et al. (2024) · Patient Preference and Adherence · doi:10.2147/ppa.s452196 · Cited by 21
Interactive Monitoring Service and COPD: Is it Possible to Reduce Nonadherence?
Blasi, F., Raddi, F., & Miravitlles, M. (2014) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.933796 · Cited by 13
Mastrodicasa, M., Droege, C. A., Mulhall, A. M., Ernst, N. E., Panos, R. J., & Zafar, M. A. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1276167 · Cited by 14
Toyama, T., Kawayama, T., Kinoshita, T., Imamura, Y., Yoshida, M., Takahashi, K., Fujii, K., Higashimoto, I., & Hoshino, T. (2018) · Internal Medicine · doi:10.2169/internalmedicine.0488-17 · Cited by 14
Wilkinson, T. M. A., North, M., & Bourne, S. C. (2014) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2014.35 · Cited by 14
Do not do in COPD: consensus statement on overuse
Álvarez, F. V., Moreno-Zabaleta, R., Mira, J. J., Corbella, E. C., Lobato, S. D., González-Torralba, F., Hernando-Sanz, A., Núñez-Palomo, S., Salgado-Aranda, S., Simón-Rodríguez, B., et al. (2018) · International Journal of COPD · doi:10.2147/copd.s151939 · Cited by 15
Patterns and Predictors of Air Cleaner Adherence Among Adults with COPD
Lorizio, W., Woo, H., McCormack, M. C., Liu, C., Putcha, N., Wood, M., Green, T., Kaviany, P., Belz, D. C., Fawzy, A., et al. (2022) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2022.0309 · Cited by 13
Jarab, A. S., Al-Qerem, W. A., Alzoubi, K. H., Heshmeh, S. A., Mukattash, T. L., Naser, A. Y., & Hamarneh, Y. N. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293342 · Cited by 14
A Critical Analysis of All-Cause Deaths during COVID-19 Vaccination in an Italian Province
Alessandria, M., Malatesta, G., Berrino, F., & Donzelli, A. (2024) · Microorganisms · doi:10.3390/microorganisms12071343 · Cited by 13
Delivery and adherence with inhaled therapy in asthma
Biddiscombe, M. F., & Usmani, O. S. (2021) · Minerva Medica · doi:10.23736/s0026-4806.20.07276-6 · Cited by 13
Norris, P., Cousins, K., Horsburgh, S., Keown, S., Churchward, M., Samaranayaka, A., Smith, A. J., & Marra, C. A. (2023) · BMC Health Services Research · doi:10.1186/s12913-022-09011-0 · Cited by 14
Zysman, M., Mahay, G., Guibert, N. M., Barnig, C., Leroy, S., & Guilleminault, L. (2023) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2023.101035 · Cited by 15
Noteboom, B., JENKINS, S. C., Maiorana, A., Cecins, N. M., Ng, C. L. W., & Hill, K. (2013) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000036 · Cited by 13
Arfè, A., Nicotra, F., Cerveri, I., de Marco, R., Vaghi, A., Merlino, L. G., & Corrao, G. (2016) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2016.1141877 · Cited by 13
Jing, X., Li, Y., & Xu, J. (2018) · Canadian Respiratory Journal · doi:10.1155/2018/7097540 · Cited by 13
Königsdorfer, N., Jörres, R. A., Söhler, S., Welte, T., Behr, J., Ficker, J. H., Bals, R., Watz, H., Lutter, J. I., Lucke, T., et al. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s223438 · Cited by 13
Medication adherence in COPD: what have we learned?
Han, M. K. (2009) · Thorax · doi:10.1136/thx.2009.121806 · Cited by 13
Igboekwe, E., Verma, S., & Paczkowski, R. (2024) · International Journal of COPD · doi:10.2147/copd.s423993 · Cited by 12
Two-year mortality of patients with COPD in primary health care: an observational study
Gourgoulianis, Verou-Katsarou, Mystridou, Apostolidou, Hatzoglou, & Gourgoulianis (2012) · International Journal of General Medicine · doi:10.2147/ijgm.s27411 · Cited by 12
Defining Optimal Medication Adherence for Persistent Asthma and COPD
Stempel, D. A., Kaye, L., & Bender, B. G. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.07.034 · Cited by 12
Yawn, B. P., McCreary, G. M., Linnell, J., Pasquale, C. B., Malanga, E., Choate, R., Stempel, D. A., Gondalia, R., Kaye, L., Collison, K. A., et al. (2021) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2021.0218 · Cited by 12
Driesenaar, J. A., Smet, P. A. G. M. D., van Hulten, R., Horne, R., Zwikker, H. E., van den Bemt, B. J. F., & van Dulmen, S. (2016) · Journal of Asthma · doi:10.1080/02770903.2016.1180696 · Cited by 12
Adherence to COPD free triple inhaled therapy in the real world: a primary care based study
Zucchelli, A., Vetrano, D. L., Bianchini, E., Lombardo, F. P., Piraino, A., Zibellini, M., Rícci, A., Marengoni, A., Lapi, F., & Cricelli, C. A. (2020) · The Clinical Respiratory Journal · doi:10.1111/crj.13190 · Cited by 12
Moretz, C., Cole, A. L., Mu, G., Wu, B., Guisinger, A., Liu, Y., Hahn, B. A., & Baylis, L. (2020) · International Journal of COPD · doi:10.2147/copd.s259850 · Cited by 12
Anbese, Z. K., Mega, T. A., Tesfaye, B. T., & Negera, G. Z. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239665 · Cited by 12
Romagnoli, A., Santoleri, F., & Costantini, A. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1841617 · Cited by 12
Price, D. B., Jones, R. C. M., Pfister, P., Cao, H., Carter, V. A., Kemppinen, A., Holzhauer, B., Kaplan, A. G., Clark, A., Halpin, D. M. G., et al. (2021) · Pragmatic and Observational Research · doi:10.2147/por.s302809 · Cited by 12
Bhattarai, A., Shakya, R., & Bista, D. (2024) · Patient Preference and Adherence · doi:10.2147/ppa.s460810 · Cited by 15
Levy, M. L., Kocks, J. W. H., Bosnic-Anticevich, S. Z., SAFIOTI, G. G., Reich, M., DePietro, M. R., Castro, M., Farooqui, N., Lugogo, N. L., Brown, R., et al. (2024) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-024-00382-x · Cited by 11
Jokšaitė, S., Wood, R. P., Ismaila, A., Camidge, L. J., Mizukami, A., Czira, A., Massey, O., Yarita, M., Compton, C., Siddiqui, R., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080864 · Cited by 11
Lack of Clinical Control in COPD Patients Depending on the Target and the Therapeutic Option
Soler‐Cataluña, J. J., Huerta, A. H., Almagro, P., Alsina, D. G.-S., & Cosío, B. G. (2023) · International Journal of COPD · doi:10.2147/copd.s414910 · Cited by 11
Alessandria, M., Malatesta, G., Palmo, G. D., Cosentino, M., & Donzelli, A. (2024) · F1000Research · doi:10.12688/f1000research.154058.1 · Cited by 11
Developing a specialist-nurse-led ‘COPD in-reach service’
Cope, K., Fowler, L., & Pogson, Z. E. K. (2015) · British Journal of Nursing · doi:10.12968/bjon.2015.24.8.441 · Cited by 11
Santus, P., Pecchiari, M., Tursi, F., Valenti, V., Saad, M., & Radovanovic, D. (2019) · Canadian Respiratory Journal · doi:10.1155/2019/3546056 · Cited by 11
Leiva-Fernández, J., Leiva-Fernández, F., Vazquez-Alarcon, R., Ruíz, A., Prados-Torres, D., & Barnestein‐Fonseca, P. (2014) · Drugs in Context · doi:10.7573/dic.212261 · Cited by 11
Fu, A. Z., Sun, S. X., Huang, X., & Amin, A. (2015) · International Journal of COPD · doi:10.2147/copd.s83082 · Cited by 10
Weir, D. L., Bai, Y., Thavorn, K., Guilcher, S. J. T., Kanji, S., Mulpuru, S., & Wodchis, W. P. (2023) · Annals of Epidemiology · doi:10.1016/j.annepidem.2023.12.003 · Cited by 10
Achterbosch, M., van de Hei, S. J., Dierick, B. J. H., Kocks, J. W. H., van den Berge, M., Kerstjens, H. A. M., Been-Buck, S., Klemmeier, T., van Dijk, L., & van Boven, J. F. M. (2024) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-024-00372-z · Cited by 10
Muraki, M., Ohno, T., Wada, S., Hanada, S., Sawaguchi, H., & Tohda, Y. (2014) · International Journal of COPD · doi:10.2147/copd.s56777 · Cited by 10
Hesso, I., Nabhani‐Gebara, S., & Kayyali, R. (2023) · Pharmacy · doi:10.3390/pharmacy11030094 · Cited by 10
Pini, L., & Tantucci, C. (2015) · International Journal of COPD · doi:10.2147/copd.s87696 · Cited by 10
Huurne, K. K.-T., Brusse-Keizer, M. G. J., van der Valk, P., Movig, K. L. L., van der Palen, J. A. M., & Bode, C. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s167002 · Cited by 10
Maricoto, T., Marques‐Gomes, J., Correia‐de‐Sousa, J., & Taborda‐Barata, L. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15834 · Cited by 10
Hesso, I., Kayyali, R., & Nabhani‐Gebara, S. (2019) · BMC Health Services Research · doi:10.1186/s12913-018-3814-2 · Cited by 10
Saja, M., Younis, A., Alzahrani, L., Alkhlassi, I., Aldakhil, L., Albayyat, R., Alnasser, N., Alokla, K., Alghamdi, L., Rashed, A., et al. (2025) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s509949 · Cited by 10
The evolving landscape of digital inhaler platforms and adherence support in chronic airways disease
Aung, H. W. W., Murphy, A., & Greening, N. J. (2025) · Chronic Respiratory Disease · doi:10.1177/14799731251366969 · Cited by 9
To, K. W., Lee, W. M., Choi, K. C., Yu, D. S. F., Chau, J. P. C., & Lee, I. (2013) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2013-616 · Cited by 9
Cost-related medication nonadherence in adults with COPD in the United States 2013–2020
Wen, X., Qiu, H., Yu, B., Bi, J., Gu, X., Zhang, Y., & Wang, S. (2024) · BMC Public Health · doi:10.1186/s12889-024-18333-z · Cited by 9
Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium
López-Campos, J. L., Calero, C., Ramírez, C. L., Asensio-Cruz, M. I., Martín, E. M., & Ruiz, F. Ó. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s55009 · Cited by 9
Cazzola, M., Matera, M. G., & Ora, J. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s73581 · Cited by 9
Steiropoulos, P., Bakakos, P., Hatziagorou, E., Katsaounou, P. A., Loukides, S., Papaioannou, A. Ι., Porpodis, Κ., Σαμαράς, Κ., Tzouvelekis, A., Kalafatakis, K., et al. (2021) · Pneumon · doi:10.18332/pne/144614 · Cited by 9
Update on ultra-long-acting β agonists in chronic obstructive pulmonary disease
Zafar, M. A., Droege, C. A., Foertsch, M. J., & Panos, R. J. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.942730 · Cited by 9
Opportunities in Respiratory Drug Delivery
Pritchard, J. N., & Giles, R. D. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.78 · Cited by 9
Real life profile of asthma and chronic obstructive pulmonary disease patients in Turkey
Mısırlıgil, Z., Cimrin, A. H., Günen, H., Özlü, T., Çilli, A., Akyıldız, L., Bayram, H., Gemicioğlu, B., Uzaslan, E., Abadoğlu, Ö., et al. (2017) · Tuberkuloz ve Toraks · doi:10.5578/tt.54065 · Cited by 9
Giner, J., Díaz-Pérez, D., Hernández, C., & García, R. C. (2019) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2019.1541 · Cited by 9
Yoo, K., Chung, W., Park, J., Hwang, S., Kim, T.-E., Oh, M. J., Kang, D.-R., Rhee, C., Yoon, H., Kim, T.-H., et al. (2017) · Tuberculosis and Respiratory Diseases · doi:10.4046/trd.2017.0041 · Cited by 11
Cognitive function and inhaler technique following recovery from exacerbations of COPD
Henkle, B. E., FREESE, R. L., Dahlheimer, M., Kane, C., Hoth, K. F., & Kunisaki, K. M. (2023) · ERJ Open Research · doi:10.1183/23120541.00627-2022 · Cited by 8
Triple Therapy in COPD in Real Life: Is It Better to Use Single or Multiple Inhalers?
Sposato, B., Rícci, A., Lacerenza, L. G., Petrucci, E., Cresti, A., Baratta, P., Perrella, A., Serafini, A., & Scalese, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206191 · Cited by 8
High Anxiety in COPD : A Barrier to Effective Inhaler Medication Adherence and Disease Management
Chen, M., Gong, Z., Wang, J., Hu, Y., Zhang, Q., Huang, S., Liang, J., Wu, J., Zhao, X., Chen, Y., et al. (2025) · Journal of Clinical Nursing · doi:10.1111/jocn.17819 · Cited by 8
Which treatment for obstructive airway disease: The inhaled bronchodilators
Perrotta, F., Mazzeo, F., & Cerqua, F. S. (2017) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2017.01.003 · Cited by 8
Medication Discontinuation in Adults With COPD Discharged From the Hospital
Gershon, A. S., McGihon, R. E., Thiruchelvam, D., To, T. M., Wu, R. C., Bell, C. M., & Aaron, S. D. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.09.254 · Cited by 8
Case, M. A., & Eakin, M. N. (2023) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2023.2239708 · Cited by 11
Pattock, A. M., Locke, E. R., Hebert, P. L., Simpson, T. L., Battaglia, C. T., TRIVEDI, R. B., Swenson, E. R., Edelman, J. D., & Fan, V. S. (2023) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202211-975oc · Cited by 8
Patel, S. R., Sawyer, A. M., & Gottlieb, D. J. (2024) · SLEEP · doi:10.1093/sleep/zsae063 · Cited by 8
Transforming respiratory diseases management: a CMO-based hospital pharmaceutical care model
Tamames, B. Z., Garín, N., Calvín-Lamas, M., Jornet, S., Simón, J. M., García-Gil, S., Garcia-Rebolledo, E. M., & Morillo‐Verdugo, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1461473 · Cited by 8
The lungs need to be deflated: effects of glycopyrronium on lung hyperinflation in COPD patients
Sanguinetti, C. M. (2014) · Multidisciplinary Respiratory Medicine · doi:10.1186/2049-6958-9-19 · Cited by 7
Topp, M., Vestbo, J., & Mortensen, E. L. (2016) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.3.4.2016.0134 · Cited by 8
Self-citation
Metadata
- Authors
- Vestbo, J., Anderson, J. A., Calverley, P. M. A., Celli, B., Ferguson, G. T., Jenkins, C., Knobil, K., Willits, L. R., Yates, J. C., & Jones, P. W.
- Affiliations
- University of Manchester (GB)
- GlaxoSmithKline (United Kingdom) (GB)
- Aintree University Hospital (GB)
- Tufts University (US)
- Woolcock Institute of Medical Research (AU)
- GlaxoSmithKline (United States) (US)
- St George's, University of London (GB)
- Corresponding author
- Vestbo, J
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2009-08-23
- Volume
- 64
- Issue
- 11
- Pages
- 939-943
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2095666112
- Cited by
- 516
- References
- 32
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 36 · 2023: 35 · 2022: 30 · 2021: 34 · 2020: 45 · 2019: 36 · 2018: 33 · 2017: 32 · 2016: 31 · 2015: 35 · 2014: 45 · 2013: 31 · 2012: 17
- FWCI
- 15.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Thorax (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- chronic obstructive pulmonary disease, medication adherence, inhalation therapy, salmeterol, fluticasone propionate, all-cause mortality, hospitalization, COPD exacerbations, TORCH trial
- MeSH terms
- Fluticasone, Salmeterol Xinafoate, Administration, Inhalation, Adult, Aged, Aged, 80 and over, Albuterol, Androstadienes, Bronchodilator Agents, Drug Administration Schedule, Drug Combinations, Drug Therapy, Combination, Epidemiologic Methods, Female, Hospitalization, Humans, Male, Middle Aged, Pulmonary Disease, Chronic Obstructive, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
